Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 610707, 10 pages
http://dx.doi.org/10.1155/2012/610707
Clinical Study

Frequent Detection of Anti-Tubercular-Glycolipid-IgG and -IgA Antibodies in Healthcare Workers with Latent Tuberculosis Infection in the Philippines

1Division of Emerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Sendai, Miyagi 980-8574, Japan
2STD AIDS Cooperative Central Laboratory, San Lazaro Hospital, Manila, Philippines
3Department of Global Epidemiology, Research Centre for Zoonosis Control, Hokkaido University, Sapporo, Japan

Received 1 August 2011; Revised 12 December 2011; Accepted 26 December 2011

Academic Editor: Katalin Andrea Wilkinson

Copyright © 2012 Umme Ruman Siddiqi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, Global Tuberculosis Control: WHO Report 2011, WHO/HTM/TB/2011.16, World Health Organization, Geneva, Switzerland, 2011.
  2. L. J. Abu-Raddad, L. Sabatelli, J. T. Achterberg et al., “Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 33, pp. 13980–13985, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Pai, A. Zwerling, and D. Menzies, “Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update,” Annals of Internal Medicine, vol. 149, no. 3, pp. 177–184, 2008. View at Google Scholar · View at Scopus
  4. D. Menzies, R. Joshi, and M. Pai, “Risk of tuberculosis infection and disease associated with work in health care settings,” International Journal of Tuberculosis and Lung Disease, vol. 11, no. 6, pp. 593–605, 2007. View at Google Scholar · View at Scopus
  5. I. Latorre, X. Martinez-Lacasa, R. Font et al., “IFN-γ response on T-cell based assays in HIV-infected patients for detection of tuberculosis infection,” BMC Infectious Diseases, vol. 10, no. 348, 2010. View at Publisher · View at Google Scholar
  6. R. K. Verma and A. Jain, “Antibodies to mycobacterial antigens for diagnosis of tuberculosis,” FEMS Immunology and Medical Microbiology, vol. 51, no. 3, pp. 453–461, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Maekura, Y. Okuda, M. Nakagawa et al., “Clinical evaluation of anti-tuberculous glycolipid immunoglobulin G antibody assay for rapid serodiagnosis of pulmonary tuberculosis,” Journal of Clinical Microbiology, vol. 39, no. 10, pp. 3603–3608, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Mizusawa, M. Kawamura, M. Takamori et al., “Increased synthesis of anti-tuberculous glycolipid immunoglobulin G (IgG) and IgA with cavity formation in patients with pulmonary tuberculosis,” Clinical and Vaccine Immunology, vol. 15, no. 3, pp. 544–548, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. U. R. Siddiqi, W. Punpunich, C. Chuchottaworn et al., “Elevated anti-tubercular glycolipid antibody titers in healthy adults as well as in pulmonary TB patients in Thailand,” The International Journal of Tuberculosis and Lung Disease. In press.
  10. S. Nabeshima, M. Murata, K. Kashiwagi, M. Fujita, N. Furusyo, and J. Hayashi, “Serum antibody response to tuberculosis-associated glycolipid antigen after BCG vaccination in adults,” Journal of Infection and Chemotherapy, vol. 11, no. 5, pp. 256–258, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. S. D. Lawn and G. Churchyard, “Epidemiology of HIV-associated tuberculosis,” Current Opinion in HIV and AIDS, vol. 4, no. 4, pp. 325–333, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. P. Narain and Y. R. Lo, “Epidemiology of HIV-TB in asia,” Indian Journal of Medical Research, vol. 120, no. 4, pp. 277–289, 2004. View at Google Scholar · View at Scopus
  13. V. Sánchez-Margalet, C. Martín-Romero, J. Santos-Alvarez, R. Goberna, S. Najib, and C. Gonzalez-Yanes, “Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action,” Clinical and Experimental Immunology, vol. 133, no. 1, pp. 11–19, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Uede, Y. Katagiri, J. Iizuka, and M. Murakami, “Osteopontin, a coordinator of host defense system: a cytokine or an extracellular adhesive protein?” Microbiology and Immunology, vol. 41, no. 9, pp. 641–648, 1997. View at Google Scholar · View at Scopus
  15. G. J. Nau, G. L. Chupp, J. F. Emile et al., “Osteopontin expression correlates with clinical outcome in patients with mycobacterial infection,” American Journal of Pathology, vol. 157, no. 1, pp. 37–42, 2000. View at Google Scholar · View at Scopus
  16. G. J. Nau, L. Liaw, G. L. Chupp, J. S. Berman, B. L. M. Hogan, and R. A. Young, “Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin,” Infection and Immunity, vol. 67, no. 8, pp. 4223–4230, 1999. View at Google Scholar · View at Scopus
  17. Y. Koguchi, K. Kawakami, K. Uezu et al., “High plasma osteopontin level and its relationship with interleukin-12-mediated type 1 T helper cell response in tuberculosis,” American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 10, pp. 1355–1359, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. R. van Crevel, E. Karyadi, M. G. Netea et al., “Decreased plasma leptin concentrations in tuberculosis patients are associated with wasting and inflammation,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 2, pp. 758–763, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Kishimoto, O. Moriya, J. I. Nakamura, T. Matsushima, and R. Soejima, “Evaluation of the usefulness of a serodiagnosis kit, the determiner TBGL antibody for tuberculosis: setting reference value,” Kekkaku, vol. 74, no. 10, pp. 701–706, 1999. View at Google Scholar · View at Scopus
  20. A. Zwerling, S. van den Hof, J. Scholten, F. Cobelens, D. Menzies, and M. Pai, “Interferon-γ release assays for tuberculosis screening of healthcare workers: a systematic review,” Thorax, vol. 67, no. 1, pp. 62–70, 2012. View at Publisher · View at Google Scholar
  21. A. Nienhaus, A. Schablon, C. Le Bâcle, B. Siano, and R. Diel, “Evaluation of the interferon-γ release assay in healthcare workers,” International Archives of Occupational and Environmental Health, vol. 81, no. 3, pp. 295–300, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Tabuchi, T. Takatorige, Y. Hirayama et al., “Tuberculosis infection among homeless persons and caregivers in a high-tuberculosis-prevalence area in Japan: a cross-sectional study,” BMC Infectious Diseases, vol. 11, no. 22, 2011. View at Publisher · View at Google Scholar
  23. N. Harada, Y. Nakajima, K. Higuchi, Y. Sekiya, J. Rothel, and T. Mori, “Screening for tuberculosis infection using whole-blood interferon-γ and Mantoux testing among Japanese healthcare workers,” Infection Control and Hospital Epidemiology, vol. 27, no. 5, pp. 442–448, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Y. Kim, M. S. Park, Y. S. Kim, S. K. Kim, J. Chang, and Y. A. Kang, “Risk factors for false-negative results of QuantiFERON-TB gold in-tube assay in non-HIV-infected patients with culture-confirmed tuberculosis,” Diagnostic Microbiology and Infectious Disease, vol. 70, no. 3, pp. 324–329, 2011. View at Publisher · View at Google Scholar
  25. M. Matsumoto, T. Tanaka, T. Kaisho et al., “A novel LPS-inducible C-type lectin is a transcriptional target of NF- IL6 in macrophages,” Journal of Immunology, vol. 163, no. 9, pp. 5039–5048, 1999. View at Google Scholar · View at Scopus
  26. E. Ishikawa, T. Ishikawa, Y. S. Morita et al., “Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle,” Journal of Experimental Medicine, vol. 206, no. 13, pp. 2879–2888, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Matsunaga, T. Naka, R. S. Talekar et al., “Mycolyltransferase-mediated glycolipid exchange in mycobacteria,” Journal of Biological Chemistry, vol. 283, no. 43, pp. 28835–28841, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Z. Topić, S. Dodig, and I. Zoričić-Letoja, “Interferon-γ and immunoglobulins in latent tuberculosis infection,” Archives of Medical Research, vol. 40, no. 2, pp. 103–108, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Tezuka, Y. Abe, M. Iwata et al., “Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells,” Nature, vol. 448, no. 7156, pp. 929–933, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. I. P. Oswald, C. M. Dozois, J. F. Petit, and G. Lemaire, “Interleukin-12 synthesis is a required step in trehalose dimycolate- induced activation of mouse peritoneal macrophages,” Infection and Immunity, vol. 65, no. 4, pp. 1364–1369, 1997. View at Google Scholar · View at Scopus
  31. R. Reljic, A. Williams, and J. Ivanyi, “Mucosal immunotherapy of tuberculosis: is there a value in passive IgA?” Tuberculosis, vol. 86, no. 3-4, pp. 179–190, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Fujita, A. Ajisawa, N. Harada, K. Higuchi, and T. Mori, “Performance of a whole-blood interferon-gamma release assay with mycobacterium RD1-specific antigens among HIV-infected persons,” Clinical and Developmental Immunology, vol. 2011, Article ID 325295, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Oni, J. Patel, H. P. Gideon et al., “Enhanced diagnosis of HIV-1-associated tuberculosis by relating T-SPOT.TB and CD4 counts,” European Respiratory Journal, vol. 36, no. 3, pp. 594–600, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. H. L. David, F. Papa, P. Cruaud et al., “Relationships between titers of antibodies immunoreacting against glycolipid antigens from Mycobacterium leprae and M. tuberculosis, the Mitsuda and Mantoux reactions, and bacteriological loads: implications in the pathogenesis, epidemiology and serodiagnosis of leprosy and tuberculosis,” International Journal of Leprosy, vol. 60, no. 2, pp. 208–224, 1992. View at Google Scholar
  35. N. Simonney, P. Chavanet, C. Perronne et al., “B-cell immune responses in HIV positive and HIV negative patients with tuberculosis evaluated with an ELISA using a glycolipid antigen,” Tuberculosis, vol. 87, no. 2, pp. 109–122, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. J. A. Fling, J. R. Fischer Jr, R. N. Boswell, and M. J. Reid, “The relationship of serum IgA concentration to human immunodeficiency virus (HIV) infection: a cross-sectional study of HIV-seropositive individuals detected by screening in the United States Air Force,” Journal of Allergy and Clinical Immunology, vol. 82, no. 6, pp. 965–970, 1988. View at Google Scholar · View at Scopus
  37. S. Perry, R. Hussain, and J. Parsonnet, “The impact of mucosal infections on acquisition and progression of tuberculosis,” Mucosal Immunology, vol. 4, no. 3, pp. 246–251, 2011. View at Publisher · View at Google Scholar
  38. C. Ridruechai, S. Sakurada, H. Yanai et al., “Association between circulating full-length osteopontin and IFN-γ with disease status of tuberculosis and response to successful treatment,” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 42, no. 4, pp. 876–889, 2011. View at Google Scholar
  39. H. Chagan-Yasutan, H. Saitoh, Y. Ashino et al., “Persistent elevation of plasma osteopontin levels in HIV patients despite highly active antiretroviral therapy,” Tohoku Journal of Experimental Medicine, vol. 218, no. 4, pp. 285–292, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. D. D. Taub, A. R. Lloyd, K. Conlon et al., “Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells,” Journal of Experimental Medicine, vol. 177, no. 6, pp. 1809–1814, 1993. View at Google Scholar · View at Scopus
  41. H. Chagan-Yasutan, K. Tsukasaki, Y. Takahashi et al., “Involvement of osteopontin and its signaling molecule CD44 in clinicopathological features of adult T cell leukemia,” Leukemia Research, vol. 35, no. 11, pp. 1484–1490, 2011. View at Publisher · View at Google Scholar